Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clovis Confident, Portola Not: CHMP Decides On EU Marketing Applications

Executive Summary

Eight EU marketing authorization applications are up for an opinion this week from the CHMP, the European Medicines Agency committee that recommends whether or not products should be approved.


Related Content

Companies Reveal Likely EU Review Outcomes Against EMA Advice
Pfizer's Mylotarg Finally Gets CHMP Nod But No New Indication For Sutent
Five Drugs Set For EU Approval, Including Two Orphans
EU Delays For Portola As CHMP Trend Votes Go Good And Bad
Think Positive: Clovis Confident Of CHMP Okay For Rubraca
Decision Time At CHMP: Portola and Aegerion In Spotlight
Orphans Dominate Products Seeking End-Of-Year Joy From CHMP
Keeping Track: Flurry Of Approvals Rolls Over Into Holiday Season


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts